FDA inspection
Shaoxing Jingxin Pharmaceutical Co., Ltd: FDA inspection ending May 24, 2024
FDA inspection 1242883 · No Action Indicated (NAI) · Shaoxing
Key facts
| Inspection ID | 1242883 |
|---|---|
| Firm | Shaoxing Jingxin Pharmaceutical Co., Ltd |
| FEI number | 3006305239 |
| Address | Zhejiang Hangzhou Bay Shangyu Economic And Technological, No. 31 Weisan Rd. Hangzhou Bay Shangyu Economic & Technological Development Area |
| City | Shaoxing |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | May 24, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data